Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BBLNNASDAQ:BTTXNASDAQ:REUNNYSE:UPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBLNBabylon$0.55$0.60$0.46▼$28.50$14.10M2.42415,159 shsN/ABTTXBetter Therapeutics$0.00$0.00$0.00▼$0.03$5K0.9517,023 shs100 shsREUNReunion Neuroscience$1.12$1.12$0.63▼$5.07$13.13M2.29210,209 shsN/AUPHUpHealth$0.73$0.25▼$3.19$5.33M0.51121,201 shs348,700 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBLNBabylon0.00%0.00%0.00%0.00%0.00%BTTXBetter Therapeutics0.00%0.00%0.00%-75.00%-98.51%REUNReunion Neuroscience0.00%0.00%0.00%0.00%0.00%UPHUpHealth0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBLNBabylonN/AN/AN/AN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AREUNReunion NeuroscienceN/AN/AN/AN/AN/AN/AN/AN/AUPHUpHealthN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBLNBabylon 0.00N/AN/AN/ABTTXBetter Therapeutics 0.00N/AN/AN/AREUNReunion Neuroscience 0.00N/AN/AN/AUPHUpHealth 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBLNBabylon$1.15B0.01N/AN/A($10.29) per share-0.05BTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AREUNReunion Neuroscience$3.88M3.38N/AN/A$1.37 per share0.82UPHUpHealth$153.15M0.00N/A0.18$7.05 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBLNBabylon-$221.45M-$23.03N/A∞N/A-35.54%N/A-105.06%N/ABTTXBetter Therapeutics-$39.76MN/A0.00∞N/AN/AN/AN/A7/21/2025 (Estimated)REUNReunion Neuroscience-$36.69MN/A0.00N/AN/AN/A-91.82%-64.58%N/AUPHUpHealth-$223M-$4.50N/AN/AN/A-49.08%12.33%3.66%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBLNBabylonN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AREUNReunion NeuroscienceN/AN/AN/AN/AN/AUPHUpHealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBLNBabylonN/A1.071.07BTTXBetter TherapeuticsN/AN/AN/AREUNReunion NeuroscienceN/A3.513.51UPHUpHealthN/A0.130.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBLNBabylon37.90%BTTXBetter Therapeutics34.00%REUNReunion Neuroscience12.88%UPHUpHealth23.35%Insider OwnershipCompanyInsider OwnershipBBLNBabylon38.52%BTTXBetter Therapeutics51.40%REUNReunion NeuroscienceN/AUPHUpHealth41.27%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBLNBabylon1,89525.61 million15.75 millionNot OptionableBTTXBetter Therapeutics4049.86 million24.23 millionOptionableREUNReunion Neuroscience1611.72 millionN/ANot OptionableUPHUpHealth61117.78 million10.44 millionOptionableUPH, BTTX, BBLN, and REUN HeadlinesRecent News About These CompaniesNewsmaker: Navigating a long, bumpy road to successFebruary 20, 2025 | bizjournals.comGlocal Healthcare Systems seeks $200 million in damages from US-based UpHealth HoldingsNovember 7, 2024 | telegraphindia.comAppeal Filed Against Ex-SEBI Chief in US State Court Over Rs. 925 Crore Dispute By Uphealth HoldingsNovember 1, 2024 | ndtvprofit.comBharatPe and Ashneer Grover Reach SettlementSeptember 30, 2024 | moneylife.inUS court grants relief to former SEBI Chairman M Damodaran, vacates $25 million arbitral awardSeptember 26, 2024 | barandbench.comUS court sets aside Arbitral Tribunal’s $25 million damages against former SEBI chiefSeptember 26, 2024 | thehindubusinessline.comUS$25mn Arbitral Award against SEBI's Ex-chief M Damodaran Set Aside by US Court in Glocal-UpHealth MatterSeptember 26, 2024 | moneylife.inUS court sets aside arbitration tribunal's direction, clears former Sebi chief of $25-mn claim in Glocal disputeSeptember 26, 2024 | moneycontrol.comUS Court Sets Aside $25-Million Arbitral Award Against Former SEBI Chairperson Meleveetil DamodaranSeptember 26, 2024 | ndtvprofit.comNew US Healthcare Interpreting Giant Emerges as Cloudbreak Buys Voyce, Rebrands as EquitiAugust 29, 2024 | slator.comVestar among PE-firms hungry for foodservice; SFW sells Micromeritics at ‘strong valuation’; GTCR-backed Cloudbreak snaps up VoyceAugust 25, 2024 | pehub.comLatest Case Law Related to IBC – April to June 2023August 16, 2024 | taxguru.inIs Uphealth Inc's Stock (UPH) a Good Investment?August 7, 2024 | aaii.comHealth Minister confirms jobs will be cut amid Health NZ shake-upJuly 23, 2024 | newstalkzb.co.nzCEO of bankrupt health company resignsJuly 20, 2024 | bizjournals.comUpHealth Announces CEO Transition and Organizational ChangesJuly 15, 2024 | prnewswire.comFiling Information In Sealed Covers For Enforcement Of Arbitral Award Is Contrary To Natural Justice: Calcutta High CourtMay 24, 2024 | livelaw.inIs India the promised arbitration hub or an enforcement/execution nightmare?May 23, 2024 | barandbench.comCalcutta HC dismisses Glocal Healthcare's pleas seeking to submit affidavits of assets in ‘sealed cover’May 22, 2024 | punjabnewsexpress.comCalcutta HC dismisses Glocal Healthcare's pleas seeking to submit affidavits of assets in ‘sealed coMay 22, 2024 | daijiworld.comUPH, BTTX, BBLN, and REUN Company DescriptionsBabylon NYSE:BBLNBabylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company provides Babylon Cloud and clinical services. Babylon Holdings Limited was founded in 2013 and is headquartered in Austin, Texas.Better Therapeutics NASDAQ:BTTX$0.0001 0.00 (0.00%) As of 10:20 AM EasternBetter Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.Reunion Neuroscience NASDAQ:REUNReunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America. The company's lead asset includes RE104, a clinical-stage serotonergic psychedelic therapeutic product for antidepressant applications. It is also developing the RE200 series, which comprises molecules that are structurally designed to be similar to classical psychedelics with selective potency at the target serotonin 2A receptor (5HT2A) for potential chronic treatment in various patient populations and indications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.UpHealth NYSE:UPHUpHealth, Inc., together with its subsidiaries, operates as a digital health services company in the Americas, Europe, and Asia. The company operates through three segments Integrated Care Management, Virtual Care Infrastructure, and Services segments. The Integrated Care Management segment offers SyntraNet, an integrated health management platform that enables clinical and community-based care teams to share information, coordinate care, manage utilization, and improve health outcomes for individuals and populations. The Virtual Care Infrastructure segment provides the Martti platform, a digital health infrastructure that enables its partners to implement unique, private-label telehealth strategies customized to their specific needs and markets, including integrated telehealth and language access services. Its platform also offers telemedicine, such as telestroke, teleneurology, and telepsychiatry services. The Services segment offers behavioral health and pharmacy services, as well as operates HelloLyf CX platform for digital dispensary services and HelloLyf HX platform for digital hospital services; and provides diagnostic laboratory testing services. UpHealth, Inc. was founded in 2019 and is headquartered in Delray Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
